BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 36110989)

  • 21.
    Zhang XZ; Chen MJ; Fan PM; Jiang W; Liang SX
    Int J Gen Med; 2022; 15():2727-2745. PubMed ID: 35300128
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic value and immune regulatory role of dynamin 1-like in lung adenocarcinoma.
    Song W; Wu X; Wang S; Barr MP; Rodríguez M; Oh IJ; Wu Y; Li D
    Transl Lung Cancer Res; 2023 Dec; 12(12):2476-2493. PubMed ID: 38205213
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elevated Heterogeneous Nuclear Ribonucleoprotein C Expression Correlates With Poor Prognosis in Patients With Surgically Resected Lung Adenocarcinoma.
    Guo W; Huai Q; Zhang G; Guo L; Song P; Xue X; Tan F; Xue Q; Gao S; He J
    Front Oncol; 2020; 10():598437. PubMed ID: 33569346
    [TBL] [Abstract][Full Text] [Related]  

  • 24.
    Wang Y; Wen H; Sun D
    Ann Transl Med; 2022 May; 10(9):519. PubMed ID: 35928739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. METTL7B is a novel prognostic biomarker of lower-grade glioma based on pan-cancer analysis.
    Jiang Z; Yin W; Zhu H; Tan J; Guo Y; Xin Z; Zhou Q; Cao Y; Wu Z; Kuang Y; Li C; Xie D; Huang H; Zhao M; Jiang X; Wang L; Ren C
    Cancer Cell Int; 2021 Jul; 21(1):383. PubMed ID: 34281539
    [TBL] [Abstract][Full Text] [Related]  

  • 26.
    Gao Y; Li Y; Song Z; Jin Z; Li X; Yuan C
    J Oncol; 2022; 2022():6509028. PubMed ID: 35847356
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FUT4 is involved in PD-1-related immunosuppression and leads to worse survival in patients with operable lung adenocarcinoma.
    Liu C; Li Z; Wang S; Fan Y; Zhang S; Yang X; Hou K; Tong J; Hu X; Shi X; Wang X; Liu Y; Che X; Qu X
    J Cancer Res Clin Oncol; 2019 Jan; 145(1):65-76. PubMed ID: 30357521
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NcRNA-Mediated High Expression of
    Jiang X; Tang L; Yuan Y; Wang J; Zhang D; Qian K; Cho WC; Duan L
    Front Oncol; 2022; 12():846536. PubMed ID: 35311097
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic Potential of METTL7B in Glioma.
    Fu R; Luo X; Ding Y; Guo S
    Neuroimmunomodulation; 2022; 29(3):186-201. PubMed ID: 35034026
    [TBL] [Abstract][Full Text] [Related]  

  • 30. H2A Histone Family Member Z (H2AFZ) Serves as a Prognostic Biomarker in Lung Adenocarcinoma: Bioinformatic Analysis and Experimental Validation.
    Li Z; Hu M; Qiu J; Feng J; Zhang R; Wu H; Hu G; Ren J
    Med Sci Monit; 2022 Jan; 28():e933447. PubMed ID: 35027526
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plakophilin-2 accelerates cell proliferation and migration through activating EGFR signaling in lung adenocarcinoma.
    Hao XL; Tian Z; Han F; Chen JP; Gao LY; Liu JY
    Pathol Res Pract; 2019 Jul; 215(7):152438. PubMed ID: 31126818
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CDCA4 as a novel molecular biomarker of poor prognosis in patients with lung adenocarcinoma.
    Tan J; Chen F; Ouyang B; Li X; Zhang W; Gao X
    Front Oncol; 2022; 12():865756. PubMed ID: 36185189
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Zc3h12d, a Novel of Hypomethylated and Immune-Related for Prognostic Marker of Lung Adenocarcinoma.
    Yang B; Ji LL; Xu HL; Li XP; Zhou HG; Xiao T; Li XH; Gao ZY; Li JZ; Zhang WD; Wang GS; Li MJ
    J Inflamm Res; 2021; 14():2389-2401. PubMed ID: 34163207
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SPOCK2 Serves as a Potential Prognostic Marker and Correlates With Immune Infiltration in Lung Adenocarcinoma.
    Zhao J; Cheng M; Gai J; Zhang R; Du T; Li Q
    Front Genet; 2020; 11():588499. PubMed ID: 33244319
    [TBL] [Abstract][Full Text] [Related]  

  • 35. BTN3A2 Expression Is Connected With Favorable Prognosis and High Infiltrating Immune in Lung Adenocarcinoma.
    Lin Y; Zhou H; Li S
    Front Genet; 2022; 13():848476. PubMed ID: 35873496
    [No Abstract]   [Full Text] [Related]  

  • 36. CKS2 Overexpression Correlates with Prognosis and Immune Cell Infiltration in Lung Adenocarcinoma: A Comprehensive Study based on Bioinformatics and Experiments.
    Wang Z; Zhang M; Wu Y; Yu Y; Zheng Q; Li J
    J Cancer; 2021; 12(23):6964-6978. PubMed ID: 34729099
    [No Abstract]   [Full Text] [Related]  

  • 37. Overexpression of
    Wei D; Sun D; Sirera R; Afzal MZ; Leong TL; Li X; Wang Y
    Transl Lung Cancer Res; 2023 Jul; 12(7):1517-1538. PubMed ID: 37577299
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SNCA correlates with immune infiltration and serves as a prognostic biomarker in lung adenocarcinoma.
    Zhang X; Wu Z; Ma K
    BMC Cancer; 2022 Apr; 22(1):406. PubMed ID: 35421944
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interferon Regulatory Factor 4 Correlated With Immune Cells Infiltration Could Predict Prognosis for Patients With Lung Adenocarcinoma.
    Li X; Zhai S; Zhang J; Zhang D; Wang S; Wang L; Yu J
    Front Oncol; 2021; 11():698465. PubMed ID: 34195096
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    Jiang F; Huang X; Yang X; Zhou H; Wang Y
    Front Oncol; 2022; 12():795971. PubMed ID: 35814368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.